Rank;Global Rank;Institution;Country;Sector
1;85;MedImmune, LLC.;USA;Companies
2;120;Regeneron Pharmaceuticals Inc;USA;Companies
3;126;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
4;127;IBM United States;USA;Companies
5;128;Hoffmann-La Roche Ltd, United States;USA;Companies
6;134;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
7;140;Novartis Institutes for Biomedical Research, United States;USA;Companies
8;141;Genentech Inc;USA;Companies
9;161;Bristol-Myers Squibb Company, United States;USA;Companies
10;187;Biogen Idec, USA;USA;Companies
11;207;Sanofi, United States;USA;Companies
12;219;Merck & Co Inc, United States;USA;Companies
13;220;GlaxoSmithKline, United States;USA;Companies
14;221;AstraZeneca, United Kingdom;GBR;Companies
15;233;Siemens AG, Germany;DEU;Companies
16;239;Pfizer Inc, United States;USA;Companies
17;246;Gilead Sciences Inc, United States;USA;Companies
18;254;BMJ Group;GBR;Companies
19;260;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
20;268;Janssen Biotech Inc;USA;Companies
21;273;Amgen, USA;USA;Companies
22;283;Merck KGaA, Germany;DEU;Companies
23;286;Eli Lilly and Company, United States;USA;Companies
24;292;AstraZeneca, United States;USA;Companies
25;309;GlaxoSmithKline, United Kingdom;GBR;Companies
26;312;Novo Nordisk A/S;DNK;Companies
27;321;Janssen Research & Development, LLC;BEL;Companies
28;325;Boehringer Ingelheim, USA;USA;Companies
29;332;Boehringer Ingelheim GmbH Germany;DEU;Companies
30;333;Celgene Corp;USA;Companies
31;336;Siemens AG, USA;USA;Companies
32;338;Bayer AG, Germany;DEU;Companies
33;364;AbbVie Inc, United States;USA;Companies
34;382;Takeda Pharmaceuticals International Inc, USA;USA;Companies
35;392;Philips Research, Eindhoven;NLD;Companies
36;406;Novartis, Switzerland;CHE;Companies
36;406;VTT Technical Research Centre of Finland;FIN;Companies
38;427;Daiichi Sankyo Co., Ltd. Japan;JPN;Companies
39;441;AstraZeneca, Sweden;SWE;Companies
40;442;GlaxoSmithKline, Belgium;BEL;Companies
41;443;Shionogi & Co Ltd;JPN;Companies
42;451;Danone Nederland BV;NLD;Companies
43;456;BASF, Germany;DEU;Companies
44;457;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
45;458;Siemens Healthineers, USA;USA;Companies
46;465;Novartis Pharmaceuticals, United States;USA;Companies
47;472;Takeda Pharmaceutical Co Inc, Japan;JPN;Companies
48;494;Nestle Switzerland;CHE;Companies
49;500;Translational Research Institute;AUS;Companies
50;501;Bayer Corp, USA;USA;Companies
51;520;Pfizer Inc, United Kingdom;GBR;Companies
52;531;UCB Pharma SA, Brussels;BEL;Companies
53;539;Lockheed Martin Corp *;USA;Companies
54;555;SINTEF Group;NOR;Companies
55;557;Astellas Pharma Inc;JPN;Companies
56;560;GeneDx;USA;Companies
57;572;Allergan plc, USA;USA;Companies
58;597;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
59;606;Springer Nature, New Zealand;NZL;Companies
60;618;RTI Health Solutions;USA;Companies
61;620;Johnson & Johnson, United States;USA;Companies
62;630;IMEC International;BEL;Companies
63;656;EMMES Corp;USA;Companies
64;658;Nippon Telegraph and Telephone Corp, Japan;JPN;Companies
65;701;Elsevier, France;FRA;Companies
66;723;ARUP Laboratories;USA;Companies
67;736;Pharmaceutical Product Development LLC;USA;Companies